Streetbeat News

Price Targets

PRTK

HC Wainwright & Co. analyst Ed Arce downgraded Paratek Pharmaceuticals (NASDAQ:PRTK) from Buy to Neutral and announced a $2.15 price target.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 10:51 am

AAPL

Wedbush analyst Daniel Ives raises Apple's price target from $205 to $220, citing increased confidence in the upcoming iPhone 15 product cycle. Ives believes that Apple is well-positioned for a major installed base upgrade cycle, with potential ASPs reaching ~$925. Apple's stock traded 0.2% higher at $178.82 in the premarket session on Wednesday.

Portfolio Pulse from Benzinga Newsbot

June 07, 2023 | 10:50 am

CBRL

Citigroup analyst Jon Tower maintains a Sell rating on Cracker Barrel Old (NASDAQ:CBRL) and lowers the price target from $88 to $79.

Portfolio Pulse from jenniferd'souza@benzinga.com

June 07, 2023 | 10:50 am

AKRO

HC Wainwright & Co. analyst Ed Arce maintains a Buy rating on Akero Therapeutics (NASDAQ:AKRO) and raises the price target from $62 to $64.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 10:49 am

RARE

Citigroup analyst Yigal Nochomovitz maintains a Buy rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) and raises the price target from $130 to $133.

Portfolio Pulse from jenniferd'souza@benzinga.com

June 07, 2023 | 10:49 am

DOCS

Needham analyst Scott Berg reiterated a Buy rating on Doximity (NYSE:DOCS) and maintained a $45 price target.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 10:47 am

CIEN

Needham analyst Alex Henderson maintains a Buy rating on Ciena (NYSE:CIEN) but lowers the price target from $70 to $60.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 10:46 am

DOCU

Citigroup analyst Tyler Radke maintains a Buy rating on DocuSign (NASDAQ: DOCU) but lowers the price target from $80 to $73.

Portfolio Pulse from jenniferd'souza@benzinga.com

June 07, 2023 | 10:34 am

CBRL

UBS analyst Dennis Geiger maintains a Neutral rating on Cracker Barrel Old (NASDAQ:CBRL) and lowers the price target from $110 to $100.

Portfolio Pulse from jenniferd'souza@benzinga.com

June 07, 2023 | 10:33 am

NFLX

Wells Fargo analyst Steven Cahall maintains an Overweight rating on Netflix (NASDAQ:NFLX) and raises the price target from $400 to $500.

Portfolio Pulse from jenniferd'souza@benzinga.com

June 07, 2023 | 10:30 am